Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease.

Stirnadel-Farrant HA, Luo J, Kler L, Cizman B, Jones D, Brunelli SM, Cobitz AR.

BMC Nephrol. 2018 Jun 11;19(1):135. doi: 10.1186/s12882-018-0925-2.

2.

Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease.

Rhee CM, Kalantar-Zadeh K, Ravel V, Streja E, You AS, Brunelli SM, Nguyen DV, Brent GA, Kovesdy CP.

Mayo Clin Proc. 2018 May;93(5):573-585. doi: 10.1016/j.mayocp.2018.01.024.

PMID:
29728200
3.

Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.

Brunelli SM, Van Wyck DB, Njord L, Ziebol RJ, Lynch LE, Killion DP.

J Am Soc Nephrol. 2018 Apr;29(4):1336-1343. doi: 10.1681/ASN.2017080870. Epub 2018 Feb 22.

PMID:
29472415
4.

Vocational activity and health insurance type among patients with end-stage renal disease: association with outcomes.

Luo J, Lee A, Cohen DE, Colson C, Brunelli SM.

J Nephrol. 2018 Aug;31(4):577-584. doi: 10.1007/s40620-018-0478-2. Epub 2018 Feb 7.

PMID:
29417389
5.

Effects of Oral Nutritional Supplements on Mortality, Missed Dialysis Treatments, and Nutritional Markers in Hemodialysis Patients.

Benner D, Brunelli SM, Brosch B, Wheeler J, Nissenson AR.

J Ren Nutr. 2018 May;28(3):191-196. doi: 10.1053/j.jrn.2017.10.002. Epub 2017 Dec 6.

PMID:
29221626
6.

The Precision of Standardized Hospitalization, Readmission, and Mortality Ratios for Dialysis Facilities.

Brunelli SM, Walker AG.

Am J Kidney Dis. 2018 Feb;71(2):291-294. doi: 10.1053/j.ajkd.2017.09.006. Epub 2017 Nov 20. No abstract available.

PMID:
29162335
7.

Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients.

Brunelli SM, Spiegel DM, Du Mond C, Oestreicher N, Winkelmayer WC, Kovesdy CP.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1207-1214. doi: 10.1093/ndt/gfx241.

8.

Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis.

Yu J, Ravel VA, You AS, Streja E, Rivara MB, Potukuchi PK, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K, Rhee CM.

Am J Nephrol. 2017;46(3):195-203. doi: 10.1159/000480302. Epub 2017 Sep 1.

9.

Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis.

Rhee CM, Chen Y, You AS, Brunelli SM, Kovesdy CP, Budoff MJ, Brent GA, Kalantar-Zadeh K, Nguyen DV.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1274-1283. doi: 10.2215/CJN.13211216. Epub 2017 Jul 13.

10.

Association of Glycemic Status During Progression of Chronic Kidney Disease With Early Dialysis Mortality in Patients With Diabetes.

Rhee CM, Kovesdy CP, Ravel VA, Streja E, Brunelli SM, Soohoo M, Sumida K, Molnar MZ, Brent GA, Nguyen DV, Kalantar-Zadeh K.

Diabetes Care. 2017 Aug;40(8):1050-1057. doi: 10.2337/dc17-0110. Epub 2017 Jun 7.

11.

In-center hemodialysis absenteeism: prevalence and association with outcomes.

Gray KS, Cohen DE, Brunelli SM.

Clinicoecon Outcomes Res. 2017 May 24;9:307-315. doi: 10.2147/CEOR.S136577. eCollection 2017.

12.

Measuring patient experience in dialysis: a new paradigm of quality assessment.

Rhee CM, Brunelli SM, Subramanian L, Tentori F.

J Nephrol. 2018 Apr;31(2):231-240. doi: 10.1007/s40620-017-0401-2. Epub 2017 Apr 21. Review.

PMID:
28432639
13.

Thyroid Status and Mortality in a Prospective Hemodialysis Cohort.

Rhee CM, You AS, Nguyen DV, Brunelli SM, Budoff MJ, Streja E, Nakata T, Kovesdy CP, Brent GA, Kalantar-Zadeh K.

J Clin Endocrinol Metab. 2017 May 1;102(5):1568-1577. doi: 10.1210/jc.2016-3616.

14.

Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort.

Kim T, Rhee CM, Streja E, Obi Y, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2017 Feb 1;32(2):370-377. doi: 10.1093/ndt/gfw012.

PMID:
28186572
15.

Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval.

Brunelli SM, Du Mond C, Oestreicher N, Rakov V, Spiegel DM.

Am J Kidney Dis. 2017 Jul;70(1):21-29. doi: 10.1053/j.ajkd.2016.10.024. Epub 2017 Jan 19.

16.

Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Model.

Brunelli SM, Sibbel SP, Van Wyck D, Sharma A, Hsieh A, Chertow GM.

Drugs R D. 2017 Mar;17(1):159-166. doi: 10.1007/s40268-016-0163-7.

17.

Dialysate temperature of 36 °C: association with clinical outcomes.

Gray KS, Cohen DE, Brunelli SM.

J Nephrol. 2018 Feb;31(1):129-136. doi: 10.1007/s40620-016-0369-3. Epub 2016 Dec 20.

PMID:
28000088
18.
19.

Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, Nissenson AR, Jadoul M, Locatelli F, Winkelmayer WC, Port FK, Robinson BM, Tentori F.

Am J Kidney Dis. 2017 Feb;69(2):266-277. doi: 10.1053/j.ajkd.2016.09.015. Epub 2016 Nov 17.

20.

Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study.

Assimon MM, Nguyen T, Katsanos SL, Brunelli SM, Flythe JE.

BMC Nephrol. 2016 Nov 11;17(1):173.

21.

The association between cinacalcet use and missed in-center hemodialysis treatment rate.

Brunelli SM, Sibbel S, Dluzniewski PJ, Cooper K, Bensink ME, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1287-1294. doi: 10.1002/pds.4050. Epub 2016 Jun 27.

PMID:
27346298
22.

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients.

Luo J, Jensen DE, Maroni BJ, Brunelli SM.

Am J Kidney Dis. 2016 Nov;68(5):763-771. doi: 10.1053/j.ajkd.2016.05.031. Epub 2016 Aug 12.

23.

The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients.

Sibbel S, Maroni BJ, Brunelli SM.

J Nephrol. 2017 Dec;30(6):821-829. doi: 10.1007/s40620-016-0350-1. Epub 2016 Sep 19.

24.

Clinical and economic burden of bloodstream infections in critical care patients with central venous catheters.

Brunelli SM, Turenne W, Sibbel S, Hunt A, Pfaffle A.

J Crit Care. 2016 Oct;35:69-74. doi: 10.1016/j.jcrc.2016.04.035. Epub 2016 May 14.

PMID:
27481738
25.

Comparative Effectiveness of Dialyzers: A Longitudinal, Propensity Score-Matched Study of Incident Hemodialysis Patients.

Sibbel S, Hunt A, Laplante S, Beck W, Gellens M, Brunelli SM.

ASAIO J. 2016 Sep-Oct;62(5):613-22. doi: 10.1097/MAT.0000000000000409.

26.

Mean platelet volume and mortality risk in a national incident hemodialysis cohort.

Kim S, Molnar MZ, Fonarow GC, Streja E, Wang J, Gillen DL, Mehrotra R, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K, Rhee CM.

Int J Cardiol. 2016 Oct 1;220:862-70. doi: 10.1016/j.ijcard.2016.06.074. Epub 2016 Jun 23.

27.

Serum sodium and mortality in a national peritoneal dialysis cohort.

Ravel VA, Streja E, Mehrotra R, Sim JJ, Harley K, Ayus JC, Amin AN, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K, Rhee CM.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1224-1233. doi: 10.1093/ndt/gfw254.

28.

Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients.

Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K.

J Am Soc Nephrol. 2016 Dec;27(12):3758-3768. Epub 2016 May 11.

29.

Use of prescription drug claims data to identify lipid-lowering medication exposure in pharmacoepidemiology studies: potential pitfalls.

Brunelli SM.

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):844-6. doi: 10.1002/pds.4017. Epub 2016 May 4. No abstract available.

PMID:
27146367
30.

Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients.

Sandoval Y, Herzog CA, Love SA, Cao J, Hu Y, Wu AH, Gilbertson D, Brunelli SM, Young A, Ler R, Apple FS.

Clin Chem. 2016 Apr;62(4):631-8. doi: 10.1373/clinchem.2015.251835. Epub 2016 Feb 4.

31.

Medicare Advantage associated with lower mortality for incident dialysis patients.

Brunelli SM, Sibbel S, Colson C, Hunt A, Nissenson AR, Krishnan M.

Nephrol News Issues. 2015 Dec;29(13):16-7, 21, 26-9.

PMID:
26767249
32.

A Comparison of Clinical Parameters and Outcomes over 1 Year in Home Hemodialysis Patients Using 2008K@home or NxStage System One.

Brunelli SM, Wilson SM, Ficociello LH, Mullon C, Diaz-Buxo JA.

ASAIO J. 2016 Mar-Apr;62(2):182-9. doi: 10.1097/MAT.0000000000000315.

PMID:
26692402
33.

Sodium modelling to reduce intradialytic hypotension during haemodialysis for acute kidney injury in the intensive care unit.

Lynch KE, Ghassemi F, Flythe JE, Feng M, Ghassemi M, Celi LA, Brunelli SM.

Nephrology (Carlton). 2016 Oct;21(10):870-7. doi: 10.1111/nep.12677.

34.

Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.

Luo J, Brunelli SM, Jensen DE, Yang A.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):90-100. doi: 10.2215/CJN.01730215. Epub 2015 Oct 23.

35.

Lean Body Mass and Survival in Hemodialysis Patients and the Roles of Race and Ethnicity.

Wang J, Streja E, Rhee CM, Soohoo M, Feng M, Brunelli SM, Kovesdy CP, Gillen D, Kalantar-Zadeh K, Chen JL.

J Ren Nutr. 2016 Jan;26(1):26-37. doi: 10.1053/j.jrn.2015.07.003. Epub 2015 Oct 21.

36.

Pre-dialysis serum sodium and mortality in a national incident hemodialysis cohort.

Rhee CM, Ravel VA, Ayus JC, Sim JJ, Streja E, Mehrotra R, Amin AN, Nguyen DV, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2016 Jun;31(6):992-1001. doi: 10.1093/ndt/gfv341. Epub 2015 Sep 25.

37.

Stage 2 hypertension: predictors of failure to achieve blood pressure control and the impact of adding one additional antihypertensive class.

Rowan CG, Flory J, Stempniewicz N, Cuddeback J, Brunelli SM.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1170-9. doi: 10.1002/pds.3849. Epub 2015 Sep 9.

PMID:
26351176
38.

Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.

Sibbel SP, Koro CE, Brunelli SM, Cobitz AR.

BMC Nephrol. 2015 Aug 18;16:144. doi: 10.1186/s12882-015-0138-x.

39.

Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation.

Brunelli SM, Dluzniewski PJ, Cooper K, Do TP, Sibbel S, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1058-67. doi: 10.1002/pds.3845. Epub 2015 Aug 2.

PMID:
26238994
40.

A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients.

Cabrera C, Brunelli SM, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO, Stefánsson BV.

BMC Nephrol. 2015 Jul 22;16:113. doi: 10.1186/s12882-015-0110-9.

41.

Hypomagnesemia and Mortality in Incident Hemodialysis Patients.

Li L, Streja E, Rhee CM, Mehrotra R, Soohoo M, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K.

Am J Kidney Dis. 2015 Dec;66(6):1047-55. doi: 10.1053/j.ajkd.2015.05.024. Epub 2015 Jul 14.

42.

Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.

Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD.

Am J Kidney Dis. 2015 Oct;66(4):655-65. doi: 10.1053/j.ajkd.2015.03.038. Epub 2015 May 23.

PMID:
26015274
43.

Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.

Flythe JE, Kshirsagar AV, Falk RJ, Brunelli SM.

Clin J Am Soc Nephrol. 2015 May 7;10(5):808-16. doi: 10.2215/CJN.10201014. Epub 2015 Apr 10.

44.

Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.

Rhee CM, Nguyen DV, Moradi H, Brunelli SM, Dukkipati R, Jing J, Nakata T, Kovesdy CP, Brent GA, Kalantar-Zadeh K.

Am J Kidney Dis. 2015 Aug;66(2):313-21. doi: 10.1053/j.ajkd.2015.02.325. Epub 2015 Mar 29.

45.

In reply to 'More evidence needed before lower dialysate sodium concentrations can be recommended'.

Weiner DE, Brunelli SM.

Am J Kidney Dis. 2015 Mar;65(3):520. doi: 10.1053/j.ajkd.2014.12.011. No abstract available.

PMID:
25704047
46.

Catheter-related bacteremia and mortality in frequent nocturnal home hemodialysis.

Xue H, Li NC, Lacson E Jr, Brunelli SM, Lockridge RS.

Hemodial Int. 2015 Apr;19(2):242-8. doi: 10.1111/hdi.12245. Epub 2015 Feb 3.

PMID:
25645402
47.

Blood pressure variability among chronic dialysis patients: recent advances in knowledge.

Flythe JE, Brunelli SM.

Curr Opin Nephrol Hypertens. 2015 Mar;24(2):163-9. doi: 10.1097/MNH.0000000000000107. Review.

PMID:
25636142
48.

Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.

Rhee CM, Kim S, Gillen DL, Oztan T, Wang J, Mehrotra R, Kuttykrishnan S, Nguyen DV, Brunelli SM, Kovesdy CP, Brent GA, Kalantar-Zadeh K.

J Clin Endocrinol Metab. 2015 Apr;100(4):1386-95. doi: 10.1210/jc.2014-4311. Epub 2015 Jan 29.

49.

End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseases.

Brunelli SM, Blanchette CM, Claxton AJ, Roy D, Rossetti S, Gutierrez B.

Clinicoecon Outcomes Res. 2015 Jan 6;7:65-72. doi: 10.2147/CEOR.S76269. eCollection 2015.

50.

Associates of cardiopulmonary arrest in the perihemodialytic period.

Flythe JE, Li NC, Lin SF, Brunelli SM, Hymes J, Lacson E Jr.

Int J Nephrol. 2014;2014:961978. doi: 10.1155/2014/961978. Epub 2014 Nov 4.

Supplemental Content

Loading ...
Support Center